ATE459376T1 - Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika - Google Patents

Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika

Info

Publication number
ATE459376T1
ATE459376T1 AT02761028T AT02761028T ATE459376T1 AT E459376 T1 ATE459376 T1 AT E459376T1 AT 02761028 T AT02761028 T AT 02761028T AT 02761028 T AT02761028 T AT 02761028T AT E459376 T1 ATE459376 T1 AT E459376T1
Authority
AT
Austria
Prior art keywords
uea
mimetics
pharmaceutical formulation
ligands contained
ligands
Prior art date
Application number
AT02761028T
Other languages
English (en)
Inventor
Richard Houghten
Clemencia Pinilla
Imelda Lambkin
Daniel O'mahony
Christa Hamashin
Amy Schink
Lisa Osthues-Spindler
Original Assignee
Sarlan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarlan Ltd filed Critical Sarlan Ltd
Application granted granted Critical
Publication of ATE459376T1 publication Critical patent/ATE459376T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT02761028T 2001-07-02 2002-07-02 Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika ATE459376T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30282201P 2001-07-02 2001-07-02
US30286801P 2001-07-03 2001-07-03
PCT/US2002/020948 WO2003004062A1 (en) 2001-07-02 2002-07-02 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1

Publications (1)

Publication Number Publication Date
ATE459376T1 true ATE459376T1 (de) 2010-03-15

Family

ID=26973111

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02761028T ATE459376T1 (de) 2001-07-02 2002-07-02 Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika

Country Status (7)

Country Link
US (2) US7166296B2 (de)
EP (1) EP1404372B1 (de)
JP (1) JP2004536109A (de)
AT (1) ATE459376T1 (de)
CA (1) CA2452257A1 (de)
DE (1) DE60235549D1 (de)
WO (1) WO2003004062A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP5114713B2 (ja) * 2005-11-01 2013-01-09 国立大学法人 熊本大学 腸管免疫賦活剤
KR101138312B1 (ko) * 2009-04-13 2012-04-27 주식회사 바이오에프디엔씨 펩타이드 유도체 및 그를 포함하는 화장료 조성물
WO2012156376A1 (en) 2011-05-13 2012-11-22 Merrion Pharmaceuticals Ireland Ltd. Use of plant lectins to target leukocytes

Also Published As

Publication number Publication date
US20060276628A1 (en) 2006-12-07
US20040062796A1 (en) 2004-04-01
WO2003004062A9 (en) 2003-04-10
EP1404372A1 (de) 2004-04-07
JP2004536109A (ja) 2004-12-02
WO2003004062A1 (en) 2003-01-16
CA2452257A1 (en) 2003-01-16
DE60235549D1 (de) 2010-04-15
EP1404372B1 (de) 2010-03-03
US7166296B2 (en) 2007-01-23

Similar Documents

Publication Publication Date Title
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR0308090A (pt) conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
MXPA05002814A (es) Formulacion para agentes lipofilicos.
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
SE0301700D0 (sv) Novel compounds
NO20026255L (no) Polymere micellesammensetninger
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
FR2889811B1 (fr) Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
EA200602047A1 (ru) Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака
TR200100054T2 (tr) Paroksetin metansülfonat
NO20055838L (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
ATE320256T1 (de) Succinate des 5,8,14-triazatetracyclo(10.3.1.0 2, 11 .0 4,9 )-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
HK1068606A1 (en) Novel aminobenzoephenones
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
ATE459376T1 (de) Pharmazeutische formulierung und darin enthaltende liganden; uea-1 mimetika
DE60214476D1 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung anbieten
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties